FindTrial
Sign In

A study of the effects of integrative music module (music therapy) on side effects of chemotherapy in patients of breast cancer

Effect of an integrative music module in chemotherapy induced side effects in patients of breast cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048523
Enrollment
120
Registered
2022-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

Dr Vedika Praveen Sadhale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of breast cancer taking chemotherapy of Anthracyclins-Adriamycine or Taxanes-Paclitaxel Patients taking adjuvant/neo-adjuvant chemotherapy. Patients who are willing to participate.

Exclusion criteria

Exclusion criteria: Patients of breast cancer who are taking other chemotherapy agents like Herceptin. Patients who are not willing to participate.

Design outcomes

Primary

MeasureTime frame
Physical symptoms will be assessed based on CTCAE criteria.Timepoint: Baseline and one week after completion of chemotherapy for all 4 arms. Two arms will be assessed monthly for 4 months. Two arms will be assessed weekly for 3 months.—

Secondary

MeasureTime frame
Psychological symptoms will be assessed using Becks inventory. Quality of Life will be assessed using WHO QOL BREF questionnaireTimepoint: At baseline and at the end of the chemotherapy—

Countries

India

Contacts

Public ContactVedika Praveen Sadhale

Bharati Vidyapeeth Deemed University College of Ayurved Pune

sachin.kulkarni@bharatividyapeeth.edu9822282323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026